Clinical Trials Browser

Pioglitazone × Other hematologic neoplasm × Clear all

NCT02852486 2025-03-30

EDI-PIO

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02942758 2024-05-08

AML-ViVA

Phase 2 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04883125 2021-05-12

Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT02767063 2020-08-07

ACTIW

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT02889003 2018-03-22

PIO2STOP

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02687425 2016-02-22

SESPI

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive